[Table/Fig-3]:
Characteristic | Control Group (n=20) | Experimental Group (n=20) | Test statistics |
---|---|---|---|
Mean Age, Years (SD) | 51.0(±5.80) | 53.0(±6.40) | t: p =.49 |
Male/Female (%) | 14 (70) / 6 (30) | 16 (80) / 4 (20) | f : p = .46 |
Mean time since Stroke, in months (SD) | 5.6(±2.20) | 6.5(±2.41) | t: p =.25 |
Type of Stroke Ischemic/Haemorrhagic (%) | 5 (25) /15 (75) | 8(40)/12(60) | f : p =.09 |
Side of involment Right/Left (%) | 9 (35) /11(65) | 10 (50) /10 (50) | χ2: p =.27 |
Risk Factors (%) Modifiable/Non Modifiable/Both | 6 (30)/0/14(70) | 4(20)/2(10) /14(70) | f : p =.08 |
Mean NIHSS (SD) | 5.4(±1.53) | 5.1(±1.16) | t: p =.49 |
Brunstorm stage of recovery Stage 5/Stage 6 | 16(80) /4 (20) | 14 (70) /6 (30) | χ2: p =.15 |
FAC % -Level 3/Level 4 | 18 (90) /2 (10) | 17 (85) /3 (15) | χ2: p =.21 |
Mean MMSE (SD) | 28.5(±1) | 28.8(±1) | t: p =.49 |
AFO/Cane as assistive devices | 2/1 | 0/2 | |
Mean KVIQ Total Score (SD) | 64.5(±3.74) | 65.5(±3.48) | t: p =.39 |
MMSE = Mini-Mental State Examination; NIHSS = National Institutes of Health Stroke Scale; t = independent t test; χ2 = chi-square test; f = Fisher exact test